GenKyoTex
ExitedLeader in NOX therapies;based on the selective inhibition of NOX enzymes
Total raised
€66M
€66,136,361
Funding rounds
5
Investors
3
distinct backers
Active since
2005-12
latest 2014-12
Funding by year
EUR raised per yearFunding rounds
5 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2015-01-01 | Series D+ | €19M | BioMed Partners,VI Partners | View deal → |
| 2012-07-01 | Series C | €24M | MP Healthcare Venture Management | View deal → |
| 2011-05-01 | Series C | €19M | MP Healthcare Venture Management | View deal → |
| 2008-05-01 | Early VC | €3.5M | — | View deal → |
| 2006-01-01 | Early VC | €1.4M | — | View deal → |
Exit
Type
acquisition
Date
Nov 2014
Value
€16M
Acquiror
Calliditas Therapeutics (Sweden)
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy